A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function

por Azaro, Analía, Rodón, Jordi, Machiels, Jean-Pascal, Rottey, Sylvie, Damian, Silvia, Baird, Richard, Garcia-Corbacho, Javier, Mathijssen, Ron H. J., Clot, Pierre-François, Wack, Claudine, Shen, Liji, de Jonge, Maja J. A.
Publicado en Cancer Chemother Pharmacol (2016)

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study

por Sarantopoulos, John, Mita, Alain C., He, Aiwu, Wade, James L., Hsueh, Chung-Tsen, Morris, John C., Lockhart, A. Craig, Quinn, David I., Hwang, Jimmy, Mier, James, Zhang, Wenping, Wack, Claudine, Yin, Jian, Clot, Pierre-François, Rixe, Olivier
Publicado en Cancer Chemother Pharmacol (2017)